Valuation: Abbott Laboratories (Pakistan) Limited

Capitalization 106B 374M 319M 298M 274M 511M 32.1B 575M 3.56B 1.36B 14.97B 1.4B 1.37B 54.58B P/E ratio 2023
172x
P/E ratio 2024 23.2x
Enterprise value 100B 353M 301M 281M 258M 481M 30.25B 541M 3.35B 1.28B 14.11B 1.32B 1.3B 51.44B EV / Sales 2023
0.72x
EV / Sales 2024 1.69x
Free-Float
16.36%
Yield 2023 *
-
Yield 2024 0.81%
More valuation ratios * Estimated data
Dynamic Chart
1 day+6.57%
1 week+13.26%
Current month+13.26%
1 month+17.16%
3 months+4.16%
6 months-10.59%
Current year-11.06%
More quotes
1 week 984.98
Extreme 984.98
1,105
1 month 925.02
Extreme 925.02
1,105
Current year 790
Extreme 790
1,310
1 year 673.01
Extreme 673.01
1,310
3 years 330
Extreme 330
1,310
5 years 330
Extreme 330
1,310
10 years 302.1
Extreme 302.1
1,310
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2016-03-31
Director of Finance/CFO - 2019-10-31
Chief Tech/Sci/R&D Officer - 2011-05-31
Director TitleAgeSince
Director/Board Member - 2009-02-28
Director/Board Member - 2014-06-03
Chairman - 2022-05-29
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+6.57%+13.26%+41.14%+66.29% 379M
+2.22%+1.53%-14.19%+138.37% 694B
+0.79%+0.40%+7.61%-12.19% 374B
+1.95%+0.66%+14.84%+25.11% 331B
+1.75%+1.87%-54.65%+11.78% 308B
+0.06%-1.50%+5.38%-20.22% 259B
+0.07%-0.28%+0.42%+17.97% 240B
+1.29%-0.60%-14.15%-6.37% 216B
+1.30%+0.08%-34.91%-11.75% 203B
+1.27%+2.25%-4.63%+19.55% 158B
Average +1.74%+2.56%-5.31%+22.85% 278.32B
Weighted average by Cap. +1.35%+0.90%-10.17%+36.58%
See all sector performances

Financials

2023 2024
Net sales 55.48B 195M 166M 156M 143M 266M 16.75B 300M 1.85B 707M 7.81B 732M 717M 28.47B 68.18B 240M 205M 191M 176M 327M 20.58B 368M 2.28B 869M 9.6B 900M 881M 34.99B
Net income 262M 921K 785K 734K 675K 1.26M 79.02M 1.41M 8.75M 3.34M 36.85M 3.46M 3.38M 134M 5.23B 18.42M 15.7M 14.68M 13.5M 25.14M 1.58B 28.28M 175M 66.71M 737M 69.09M 67.66M 2.69B
Net Debt -4.88B -17.17M -14.63M -13.68M -12.58M -23.43M -1.47B -26.36M -163M -62.18M -687M -64.39M -63.06M -2.5B -6.13B -21.57M -18.39M -17.19M -15.81M -29.44M -1.85B -33.12M -205M -78.13M -863M -80.91M -79.24M -3.15B
More financial data * Estimated data
Logo Abbott Laboratories (Pakistan) Limited
Abbott Laboratories Pakistan Limited is engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. The Company operates through four segments: Pharmaceutical, Nutritional, Diagnostic, and Others. It offers treatment options for a number of areas, including the digestive system, heart health, women’s health, respiratory illness, central nervous system/pain and influenza vaccines. Its nutritional brands include Similac, PediaSure, Pedialyte, Ensure, and Glucerna. It offers tests and diagnostic tools, medical diagnostic instruments, automation and informatics solutions for hospitals, reference labs, blood centers, emergency departments, physician offices and clinics. The Company’s easy-to-use test strips require only tiny blood samples while its meters provide results and reports.
Employees
1,406
More about the company
Date Price Change Volume
25-07-08 1,086.23 -1.34% 33,922
25-07-07 1,100.93 +6.57% 102,736
25-07-04 1,033.08 -0.15% 4,585
25-07-03 1,034.60 +1.22% 21,601
25-07-02 1,022.11 +4.22% 56,836

End-of-day quote Pakistan S.E., July 06, 2025

More quotes